Literature DB >> 33199825

Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis.

Junjiang Fu1, Li Liao2, Kyathegowdanadoddi Srinivasa Balaji3, Chunli Wei2, Jaehoon Kim4, Jiangzhou Peng5.   

Abstract

RNF40 (OMIM: 607700) is a really interesting new gene (RING) finger E3 ubiquitin ligase containing multiple coiled-coil domains and a C-terminal RING finger motif, which engage in protein-DNA and protein-protein interactions. RNF40 encodes a polypeptide of 1001 amino acids with a predicted molecular mass of 113,678 Da. RNF40 and its paralog RNF20 form a stable heterodimer complex that can monoubiquitylate histone H2B at lysine 120 as well as other nonhistone proteins. Cancer is a major public health problem and the second leading cause of death. Through its protein ubiquitylation activity, RNF40 acts as a tumor suppressor or oncogene to play major epigenetic roles in cancer development, progression, and metastasis, highlighting the essential function of RNF40 and the importance of studying it. In this review, we summarize current knowledge about RNF40 gene structure and the role of RNF40 in histone H2B monoubiquitylation, DNA damage repair, apoptosis, cancer development, and metastasis. We also underscore challenges in applying this information to cancer prognosis and prevention and highlight the urgent need for additional investigations of RNF40 as a potential target for cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33199825      PMCID: PMC7819849          DOI: 10.1038/s41388-020-01556-w

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  85 in total

Review 1.  The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases.

Authors:  P K Jackson; A G Eldridge; E Freed; L Furstenthal; J Y Hsu; B K Kaiser; J D Reimann
Journal:  Trends Cell Biol       Date:  2000-10       Impact factor: 20.808

2.  Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter.

Authors:  Adam Wood; Nevan J Krogan; Jim Dover; Jessica Schneider; Jonathan Heidt; Marry Ann Boateng; Kimberly Dean; Ashkan Golshani; Yi Zhang; Jack F Greenblatt; Mark Johnston; Ali Shilatifard
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

3.  Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for degradation.

Authors:  Lih-Shen Chin; John P Vavalle; Lian Li
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

Review 4.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  A conserved RING finger protein required for histone H2B monoubiquitination and cell size control.

Authors:  William W Hwang; Shivkumar Venkatasubrahmanyam; Alexandra G Ianculescu; Amy Tong; Charles Boone; Hiten D Madhani
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

7.  Phase separation directs ubiquitination of gene-body nucleosomes.

Authors:  Laura D Gallego; Maren Schneider; Chitvan Mittal; Anete Romanauska; Ricardo M Gudino Carrillo; Tobias Schubert; B Franklin Pugh; Alwin Köhler
Journal:  Nature       Date:  2020-03-11       Impact factor: 49.962

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.

Authors:  Chunli Wei; Jingliang Cheng; Boxv Zhou; Li Zhu; Md Asaduzzaman Khan; Tao He; Sufang Zhou; Jian He; Xiaoling Lu; Hanchun Chen; Dianzheng Zhang; Yongxiang Zhao; Junjiang Fu
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

10.  Global burden of cancer.

Authors:  Xiaomei Ma; Herbert Yu
Journal:  Yale J Biol Med       Date:  2006-12
View more
  12 in total

1.  PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway.

Authors:  Ju Zhou; Saber Imani; Marzieh Dehghan Shasaltaneh; Shuguang Liu; Tao Lu; Junjiang Fu
Journal:  Mol Biol Rep       Date:  2021-11-23       Impact factor: 2.316

2.  FGFR2-BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model.

Authors:  Josh Haipeng Lei; Lei Zhang; Zhenyi Wang; Raoul Peltier; Yusheng Xie; Ganchao Chen; Shiqi Lin; Kai Miao; Chu-Xia Deng; Hongyan Sun
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

3.  Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.

Authors:  Jiang Chen; Yangjie Liao; Rui Li; Mingjiang Luo; Guanlin Wu; Ruirong Tan; Zhihong Xiao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  Protean role of epigenetic mechanisms and their impact in regulating the Tregs in TME.

Authors:  A S Smiline Girija
Journal:  Cancer Gene Ther       Date:  2021-07-28       Impact factor: 5.854

5.  Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.

Authors:  Jingliang Cheng; Ju Zhou; Shangyi Fu; Jiewen Fu; Baixu Zhou; Hanchun Chen; Junjiang Fu; Chunli Wei
Journal:  J Cell Mol Med       Date:  2021-02-20       Impact factor: 5.295

6.  RNA-Sequencing Reveals Heat Shock 70-kDa Protein 6 (HSPA6) as a Novel Thymoquinone-Upregulated Gene That Inhibits Growth, Migration, and Invasion of Triple-Negative Breast Cancer Cells.

Authors:  Shiyi Shen; Chunli Wei; Junjiang Fu
Journal:  Front Oncol       Date:  2021-05-04       Impact factor: 6.244

7.  Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.

Authors:  Hai Cai; Hang Chen; Qi Huang; Jun-Ming Zhu; Zhi-Bin Ke; Yun-Zhi Lin; Qing-Shui Zheng; Yong Wei; Ning Xu; Xue-Yi Xue
Journal:  Pathol Oncol Res       Date:  2021-10-29       Impact factor: 3.201

8.  COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2.

Authors:  Dabing Li; Xiaoyan Liu; Lianmei Zhang; Jiayue He; Xianmao Chen; Shuguang Liu; Jiewen Fu; Shangyi Fu; Hanchun Chen; Junjiang Fu; Jingliang Cheng
Journal:  Int J Biol Sci       Date:  2021-09-21       Impact factor: 6.580

Review 9.  Histone Mono-Ubiquitination in Transcriptional Regulation and Its Mark on Life: Emerging Roles in Tissue Development and Disease.

Authors:  Liat Oss-Ronen; Tzlil Sarusi; Idan Cohen
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

Review 10.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.